Acute quadriplegic myopathy in a 16-month-old child

Francesca Iodice1, Marco Salzano, Monica Prosperi

  • 1Department of Anaesthesia and Intensive Care, Ospedale Pediatrico Bambino, Gesu-Palidoro, Rome, Italy. francesca_iodice@yahoo.it

Insights

A previously healthy child developed severe acute quadriplegic myopathy (AQM) after a viral respiratory infection. This case highlights AQM

Area of Science:

  • Pediatric critical care medicine
  • Neuromuscular disorders
  • Infectious diseases

Background:

  • Acute respiratory insufficiency in children can have various etiologies.
  • Viral infections are common triggers for respiratory distress in pediatric patients.
  • Myopathies can present with significant respiratory compromise.

Observation:

  • A 16-month-old child presented with acute respiratory insufficiency, likely viral.
  • The child developed severe acute quadriplegic myopathy (AQM) requiring mechanical ventilation.
  • Initial treatment included neuromuscular blockers, corticosteroids, and antibiotics.

Findings:

  • Despite initial improvement, the child failed to wean from mechanical ventilation.
  • Diagnosis of severe acute quadriplegic myopathy (AQM) was confirmed.
  • AQM presented as a severe complication following a viral respiratory illness.

Implications:

  • This case underscores the importance of recognizing AQM in pediatric respiratory failure.
  • Early diagnosis and management of AQM are crucial for patient outcomes.
  • Further research into the pathophysiology and treatment of AQM is warranted.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...